These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2458873)

  • 21. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally.
    Jones BM; Cheng IK; Wong RW
    Clin Exp Immunol; 1991 Nov; 86(2):212-8. PubMed ID: 1718638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased numbers of CD5+ B lymphocytes in schizophrenic patients.
    McAllister CG; Rapaport MH; Pickar D; Podruchny TA; Christison G; Alphs LD; Paul SM
    Arch Gen Psychiatry; 1989 Oct; 46(10):890-4. PubMed ID: 2478093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD22 on peripheral B cells in patients with rheumatoid arthritis: relation to CD5-positive B cells.
    Nakiri Y; Minowa K; Suzuki J; Mitsuo A; Amano H; Morimoto S; Tokano Y; Takasaki Y
    Clin Rheumatol; 2007 Oct; 26(10):1721-3. PubMed ID: 17585360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro IgM rheumatoid factor production by peripheral blood mononuclear cells from patients with seronegative rheumatoid arthritis.
    Nonaka S; Yasuda M; Nobunaga M
    J Rheumatol; 1993 Sep; 20(9):1478-84. PubMed ID: 7513025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD5+ B-lymphocytes are as dependent on T-helper cells and as responsive to T-suppressor cells in pokeweed mitogen-stimulated activation as conventional CD5- B-lymphocytes.
    Jones BM
    Scand J Immunol; 1991 Apr; 33(4):387-92. PubMed ID: 1708165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frequency of Leu 1+B cells in autoantibody positive and negative autoimmune diseases and in neonatal cord blood.
    Kazbay K; Osterland CK
    Clin Exp Rheumatol; 1990; 8(3):231-5. PubMed ID: 1696190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD5 positive immunoregulatory B cell subsets.
    Paglieroni T; Caggiano V; MacKenzie M
    Am J Hematol; 1988 Aug; 28(4):276-8. PubMed ID: 2458037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in CD5+ B cells in juvenile rheumatoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity.
    Jarvis JN; Kaplan J; Fine N
    Arthritis Rheum; 1992 Feb; 35(2):204-7. PubMed ID: 1370899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of synovial fluid T cell proliferation by anti-CD5 monoclonal antibodies. A potential mechanism for their immunotherapeutic action in vivo.
    Verwilghen J; Kingsley GH; Ceuppens JL; Panayi GS
    Arthritis Rheum; 1992 Dec; 35(12):1445-51. PubMed ID: 1282008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugate.
    Cannon GW; Marble DA; Griffiths MM; Cole BC; McCall S; Schulman SF; Strand V
    J Rheumatol; 1995 Feb; 22(2):207-13. PubMed ID: 7537827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auto- and polyreactivity of IgM from CD5+ and CD5- cord blood B cells.
    Mackenzie LE; Youinou PY; Hicks R; Yuksel B; Mageed RA; Lydyard PM
    Scand J Immunol; 1991 Mar; 33(3):329-35. PubMed ID: 1707183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CD5-expressing B cells in health and disease (review).
    Pers JO; Jamin C; Predine-Hug F; Lydyard P; Youinou P
    Int J Mol Med; 1999 Mar; 3(3):239-45. PubMed ID: 10028047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis.
    Ikizawa K; Yanagihara Y; Kajiwara K; Koshio T; Shida T; Yamada A
    Int Arch Allergy Immunol; 1993; 101(4):416-24. PubMed ID: 7689005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD5 positive B cells in patients with rheumatoid arthritis: phorbol ester mediated enhancement of detection.
    Youinou P; Mackenzie L; Jouquan J; Le Goff P; Lydyard PM
    Ann Rheum Dis; 1987 Jan; 46(1):17-22. PubMed ID: 3101622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo T cell depletion in rheumatoid arthritis is associated with increased in vitro IgM-rheumatoid factor synthesis.
    Olsen NJ; Teal GP; Strand V
    Clin Immunol Immunopathol; 1993 May; 67(2):124-9. PubMed ID: 7686090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5- B lymphocytes.
    Nawata Y; Stall AM; Herzenberg LA; Eugui EM; Allison AC
    Int Immunol; 1990; 2(7):603-14. PubMed ID: 1703783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue.
    Brown CM; Longhurst C; Haynes G; Plater-Zyberk C; Malcolm A; Maini RN
    Clin Exp Immunol; 1992 Aug; 89(2):230-8. PubMed ID: 1379132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function.
    Fishwild DM; Strand V
    J Rheumatol; 1994 Apr; 21(4):596-604. PubMed ID: 7518519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The major rheumatoid factor cross-reactive idiotype is dominantly expressed by Staphylococcus aureus Cowan strain I-activated CD5+ control B cells.
    Bonagura VR; Pernis B; Agostino N; Hatam L
    Cell Immunol; 1992 Apr; 140(2):381-9. PubMed ID: 1371948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.